Ion Channel Drug Development

Novassay is pursuing its own in-house R&D to identify new leads and at the same time is forming partnership agreements with Ion Channel-focused academic centres of excellence wishing to out-license novel discoveries in a broad range of therapeutic areas where Ion Channels are implicated
We are looking for in-licensing opportunities in
 
Channelopathies: including pain, cardiovascular and rare diseases
Idiopathic Pulmonary Fibrosis (IPF)
Liver Fibrosis (LF)
Opportunities suitable for partnering include all stages from late discovery, pre-clinical and up to Phase I assets.